Abiopharma

🔍 Mintz Paul (Director)

Company: Nuo Therapeutics, Inc. (AURX)

Report Date: 2025-12-09

Detailed Transactions and Holdings:

• Acquired 50,000 shares of Common Stock at $0.4 per share (Direct)
  Date: 2025-12-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 117,385.00 | transaction_form_type: 4
• Sold 9,091 shares of Common Stock at $2.2 per share (Direct)
  Date: 2025-12-09 | Code: F | equity_swap_involved: 0 | shares_owned_after: 108,294.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 50,000 shares of Option to purchase common stock at $0.4 per share (Derivative)
  Date: 2018-12-31 | Code: M | Expires: 2025-12-31 | Exercise: 2018-12-31 | equity_swap_involved: 0 | transaction_form_type: 4

Footnotes:

• F1: Represents a net exercise of outstanding stock options. The reporting person received 40,909 shares of common stock on the net exercise of option to purchase 50,000 shares of common stock. The issuer withheld 9,091 shares of common stock underlying the option for payment of the exercise price using the closing price of $2.20.